Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is the list for Thursday, 30 January, as follows:
Acceleron Pharma Inc. (NASDAQ:XLRN) Citigroup reiterated its Buy rating and raised its target to 138 from 75.
Apple Inc. (NASDAQ:AAPL) Merrill Lynch reiterated Apple as Buy and raised its target to 350 from 340. Cowen reiterated it as Outperform and raised its target to 370 from 350. JPMorgan maintained its Overweight rating and raised its target to 350 from 300, while Citigroup reiterated its Buy rating and raised its target to 375 from 300. Evercore ISI reiterated its Outperform rating and hiked its target to 365 from 360.
DR Horton Inc. (NYSE:DHI) was reiterated as Buy and the price objective was raised to 70 from 65 at Merrill Lynch. Shares have a 63.00 consensus target price.
Facebook Inc. (NASDAQ:FB) was raised to Strong Buy from Outperform and the target price was raised to 270 from 230 at Raymond James. Merrill Lynch reiterated its Buy rating and 260 price objective on the social media leader. Facebook had a consensus target price of 249.15.
Lockheed Martin Corp. (NYSE:LMT) was reiterated as Buy and its target price was raised to 475 at Argus.
Monster Beverage Corp. (NASDAQ:MNST) was reiterated with a Buy rating and the price target was raised to 77 from 68 at Citigroup.
United Technologies Corp. (NYSE:UTX) was reiterated as Buy and the target price was raised to 170 at Argus.